FDA’s accelerated approval process for new medicinal products

This comprehensive course delves into the intricacies of the U.S. Food and Drug Administration’s (FDA) accelerated approval process, a pivotal mechanism designed to expedite the availability of new medicinal products for patients with serious conditions. Participants will explore the regulatory framework, key eligibility criteria, and the scientific and ethical considerations that underpin this fast-tracked pathway. […]

FDA’s accelerated approval process for new medicinal products Read More »